| Primary |
| Product Used For Unknown Indication |
27.3% |
| Intentional Overdose |
18.2% |
| Suicide Attempt |
18.2% |
| Depression |
13.6% |
| Hypertension |
13.6% |
| Cardiac Disorder |
4.5% |
| Migraine |
4.5% |
|
| Drug Exposure During Pregnancy |
20.0% |
| Overdose |
20.0% |
| Amnesia |
10.0% |
| Atrioventricular Block Second Degree |
10.0% |
| Blood Pressure Decreased |
10.0% |
| Drug Ineffective |
10.0% |
| Memory Impairment |
10.0% |
| Suicide Attempt |
10.0% |
|
| Secondary |
| Intentional Overdose |
25.0% |
| Suicide Attempt |
25.0% |
| Depression |
15.2% |
| Hypertension |
8.0% |
| Product Used For Unknown Indication |
3.6% |
| Maternal Exposure During Pregnancy |
2.7% |
| Migraine |
2.7% |
| Pulmonary Arterial Hypertension |
2.7% |
| Supraventricular Tachycardia |
2.7% |
| Type 2 Diabetes Mellitus |
2.7% |
| Arrhythmia |
1.8% |
| Atrial Fibrillation |
1.8% |
| Cardiogenic Shock |
0.9% |
| Dyslipidaemia |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Hypothyroidism |
0.9% |
| Leukopenia |
0.9% |
| Urinary Incontinence |
0.9% |
| Vertigo |
0.9% |
|
| Optic Ischaemic Neuropathy |
19.4% |
| Drug Ineffective |
9.7% |
| Atrioventricular Block First Degree |
6.5% |
| Disorientation |
6.5% |
| Haemorrhage |
6.5% |
| Hypotension |
6.5% |
| Atrioventricular Block Second Degree |
3.2% |
| Blindness Transient |
3.2% |
| Dyspnoea |
3.2% |
| Eosinophilia |
3.2% |
| Foetal Anticonvulsant Syndrome |
3.2% |
| Gastrointestinal Haemorrhage |
3.2% |
| Haemodynamic Instability |
3.2% |
| Hyperkalaemia |
3.2% |
| Intentional Overdose |
3.2% |
| Loss Of Consciousness |
3.2% |
| Melaena |
3.2% |
| Metabolic Acidosis |
3.2% |
| Suicide Attempt |
3.2% |
| Viith Nerve Paralysis |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.0% |
| Hypertension |
17.3% |
| Coronary Artery Bypass |
7.4% |
| Atrial Fibrillation |
4.9% |
| Rheumatoid Arthritis |
4.9% |
| Hepatitis C |
4.1% |
| Nuclear Magnetic Resonance Imaging |
4.1% |
| Diabetes Mellitus |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Angiogram |
2.7% |
| Asthma |
2.7% |
| Blood Cholesterol Increased |
2.2% |
| Dyspnoea |
2.2% |
| Multiple Sclerosis |
2.2% |
| Osteoporosis |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Catheterisation Cardiac |
1.9% |
| Depression |
1.9% |
| Migraine |
1.9% |
| Prophylaxis |
1.9% |
|
| Injury |
14.1% |
| Pain |
9.4% |
| Anxiety |
7.8% |
| Insomnia |
7.8% |
| Dyspnoea |
6.3% |
| Renal Failure |
6.3% |
| Anhedonia |
4.7% |
| Cardiac Failure Congestive |
4.7% |
| Pruritus |
4.7% |
| Arrhythmia |
3.1% |
| Atrial Fibrillation |
3.1% |
| Biliary Dyskinesia |
3.1% |
| Death |
3.1% |
| Depression |
3.1% |
| Diarrhoea |
3.1% |
| Drug Ineffective |
3.1% |
| Emphysema |
3.1% |
| Fatigue |
3.1% |
| Fear |
3.1% |
| Hospitalisation |
3.1% |
|
